The future of feasibility: AI-driven site selection & protoc...
AI can help sponsors identify higher-potential sites, improve enrolment predictability, and accelerate study startup timelines.
Newsletters and Deep Dive digital magazine
AI can help sponsors identify higher-potential sites, improve enrolment predictability, and accelerate study startup timelines.
For many years, body weight sat at the centre of obesity drug development.
In honour of National Cancer Survivors' Day, we recount three patient testimonies and calls to action from ASCO Voices at ASCO 2026.
Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.
Editor's Picks
Newsletters and Deep Dive
digital magazine